Dimitrios Rigopoulos
Overview
Explore the profile of Dimitrios Rigopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
782
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rigopoulos D, Katsantonis J, Neofotistou O, Chasapi V, Lazaridou E, Roussaki-Schulze A, et al.
J Dermatolog Treat
. 2025 Jan;
36(1):2402344.
PMID: 39870385
Objective: To characterize the systemic treatment patterns and current state of moderate-to-severe psoriasis patients in real-world settings in Greece. Methods: CRYSTAL-Greece was a multicenter, cross-sectional and retrospective chart review study...
2.
Rompoti N, Tsiori S, Kontoangelos K, Kouzoupis A, Papageorgiou C, Gregoriou S, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518563
: Psoriasis is associated with a high psychological burden and comorbidities, such as depression and anxiety. The aim of this study was to evaluate the psychopathological profile of patients with...
3.
Platsidaki E, Markantoni V, Nicolaidou E, Katoulis A, Rigopoulos D, Stratigos A, et al.
Dermatol Ther (Heidelb)
. 2024 Nov;
14(11):3183-3192.
PMID: 39485595
Introduction: Melasma is a common acquired disorder of melanogenesis that predominately affects women and presents as hyperpigmented skin lesions mainly located on the face. The study aims to investigate the...
4.
Stefanis A, Arenberger P, Arenbergerova M, Rigopoulos D
Skin Appendage Disord
. 2024 Oct;
10(5):376-382.
PMID: 39386300
Introduction: Androgenetic alopecia (AGA) is the most common type of hair loss. Platelet-rich plasma (PRP) and mesotherapy (MZT) injections of various solutions fortified with growth factors are popular treatment options...
5.
Tampouratzi E, Sfaelos K, Rigopoulos D, Pesiridis G, Kostaki M, Micali G, et al.
Skinmed
. 2024 Aug;
22(3):237-239.
PMID: 39090027
No abstract available.
6.
Rompoti N, Stefanaki I, Panagakis P, Papoutsaki M, Politou M, Vavouli C, et al.
J Eur Acad Dermatol Venereol
. 2024 Mar;
39(1):e1-e4.
PMID: 38506605
No abstract available.
7.
Sgouros D, Routsi E, Evangelodimou A, Lallas A, Apalla Z, Arvanitis D, et al.
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398285
: Dermatoscopy has been established as an important diagnostic tool for a wide range of skin diseases. This study aims to evaluate the use of dermatoscopy in clinical practice among...
8.
Kleidona I, Agiasofitou E, Tsiogka A, Chorti M, Gregoriou S, Stratigos A, et al.
Indian J Dermatol Venereol Leprol
. 2024 Feb;
:1-3.
PMID: 38314981
No abstract available.
9.
Rigopoulos D, Tampouratzi E, Angelakopoulos C, Apalla Z, Barkis I, Georgiou S, et al.
J Eur Acad Dermatol Venereol
. 2024 Feb;
38(6):1121-1130.
PMID: 38308561
Background: Despite that brodalumab's efficacy and safety have been assessed in randomized clinical trials, real-life data remain scarce. BrIDGE was an observational, prospective, single-cohort, multicentre study that recruited patients with...
10.
Maurer M, Ensina L, Gimenez-Arnau A, Sussman G, Hide M, Saini S, et al.
Lancet
. 2023 Nov;
403(10422):147-159.
PMID: 38008109
Background: Many patients with chronic spontaneous urticaria (CSU) do not achieve complete control of their symptoms with current available treatments. In a dose-finding phase 2b study, ligelizumab improved urticaria symptoms...